agilon health, inc. (NYSE: AGL) stock experienced a significant drop of 5.07% in the pre-market trading session on Friday, following the release of its full-year results and analysts' revised forecasts.

The healthcare company reported revenue in line with expectations at $6.1 billion for the fiscal year. However, it reported a larger-than-expected statutory loss of $0.63 per share, which raised concerns among investors.

Analyst projections for the upcoming year have been revised, with revenue estimates lowered to $6.10 billion, approximately in line with the previous year. Additionally, analysts expect agilon health's revenue growth to slow substantially, projecting an annualized growth rate of 0.6% compared to the historical five-year growth rate of 38%.